Q1 2025 Management View CEO Brian Goff highlighted Agios’ mission of delivering transformative therapies for rare diseases ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today reported business highlights and financial ...

Punjab Information Minister Azma Bokhari visited Sundas Foundation in Lahore, where she spent time with children battling ...

Ranchi: The health department of the Ranchi district has introduced advanced testing facilities for genetic blood disorders, ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Managing Director, Pakistan Bait-ul-Mal, Amir Fida Paracha in an interview said that approximately 100,000 patients are suffering from Thalassemia in Pakistan and every year 5,000 babies are born with ...

Oral infections are more likely to occur in people with chronic kidney disease and are more likely to become a significant problem. Proper dental care also benefits people on dialysis or those ...

The following is a summary of “Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised β-thalassemia major patients and exploring a potential correlation with von ...

They also make hormones that help to regulate blood pressure, keep bones strong, and make red blood cells. Chronic kidney disease (CKD) is when the kidneys are permanently damaged. CKD can progress to ...